INTRODUCTION
============

The epididymis is a part of the male excurrent ductal system and the place in which spermatozoa produced from the testis become mature and acquire fertilizing capacity. The epididymis has a ductal structure and is consisted of a lay of epithelial cells surrounded by smooth muscle layers ([@R15]). The epididymal epithelium possesses several cell types, including principal, narrow, basal, halo, and apical cell ([@R15]). Each cell type in the epididymal epithelium has different morphologies and functions ([@R16]). For example, principal cell, the main epithelial cell type, is characterized by columnar shape, basally localized nucleus, and well-developed secretory and endocytotic vesicles ([@R16]). On the other hand, basal cell is localized on the basement membrane of the duct and has extended shape ([@R16]). The cytoplasm of basal cell contains typical secretory granules and some endocytotic vesicles ([@R16]). Based on these histological features and physiological examinations, it is now well known that the epididymis plays in several important roles for male reproduction, such as transport, maturation, and storage of spermatozoa ([@R17], [@R16]).

The epididymis is divided into four different regions, including initial segment, caput epididymis, corpus epididymis, and caudal epididymis, based on morphological and functional characteristics ([@R2]; [@R16]). The concentration of sodium within the epididymal lumen is gradually decreased from the initial segment to the caudal epididymis, while potassium concentration becomes s increased along the epididymis ([@R16]). Luminal concentration of chloride is greatly reduced at the caput epididymis but no clear change at the corpus and caudal epididymis ([@R16]). Such changes of luminal composition along the epididymis suggest that unique microenvironment within each compartment of the epididymis is closely related with proper sperm maturation ([@R16]). Segmental specification of the epididymis is also found in different distribution of epithelial cell types. For instance, the proposition of the principal cell along the epididymis varies from 65% to 80% of the total cell population of the epididymal epithelium ([@R18]). Such compositional difference of cell types among the epididymal regions is considered to in part contribute the creation of segmental-specific microenvironment ([@R18]).

The formation and maintenance of distinct microenvironments within different epididymal segments are the result of a complex coordination among cells. A way to accomplish such accordance between neighboring cells is a direct cell-cell communication via gap junction. The gap junction is a specialized intercellular channel which connects the cytoplasm of adjacent cells and allows direct movement of small molecules, ions, and various intracellular signal particles ([@R4]). The gap junction is made of connexin (*Cx*) molecule, and at least, twenty *Cx* isoforms have been identified in human and rodents ([@R19]). The presence and expression of tissue-specific *Cx* isoforms have been determined by several researches ([@R4]; [@R19]). The differential expression of *Cx* isoforms in the epididymis during postnatal period has been demonstrated by our previous and other researches ([@R3]; [@R5]; [@R7]; [@R13]). Moreover, our recent findings have demonstrated that expression of *Cx* isoforms in the initial segment and corpus epididymis is differentially regulated by estradiol benzoate, an agonist of estradiol, or flutamide, a synthetic antiandrogen, which is administrated at the early neonatal and/or weaning age ([@R8]; [@R10]). However, the effect of estradiol benzoate or flutamide on the expression of *Cx* isoforms in other epididymal regions has not been determined.

It is well accepted that functions of the epididymis are generally regulated by androgen and in part estrogen ([@R6]; [@R14]). Thus, in the current examination, expressional changes of *Cx* isoforms in the caudal epididymis of adult rat treated with estradiol benzoate or flutamide at 7 days of postnatal age was investigated by quantitative real-time PCR analysis.

MATERIALS AND METHODS
=====================

1.. Experimental animals and design of study
--------------------------------------------

Male Spragure Dawley rats at 7 days of postnatal age were obtained from pregnant female rats (n=5), which were purchased from Samtako (OSan, Korea) and were individually caged upon the arrival and randomly assigned into 5 different experimental groups, control, low-dose estradiol benzoate (EB) treated (EB-L), high-dose EB treated (EB-H), lowdose flutamide treated (Flu-L), and high-dose flutamide treated (Flu-H) group. Animals were allowed to freely access to food and drinking water for entire experimental period. The present study was carried out in accordance with the guide for the care and use of laboratory animals of National Research Council in S. Korea.

The EB and flutamide were purchased from Tokyo Chemical Industry Co. (Tokyo, Japan). The powder of EB or flutamide was dissolved in 100% EtOH with stirring at room temperature to make the stock solution, and a series of dilution of the stock solution in peanut oil were carried out for preparation of working solution. When male pups at 7 days of age were acquired, the weight of each animal was measured, and a proper amount of working solution of EB or flutamide was subcutaneously injected to make a final concentration of 0.015 mg/kg body weight (BW) for EB-L, 1.5 mg/kg BW for EB-H, 500 mg/kg BW for Flu-L, or 50 mg/Kg BW for Flu-H. Animals in control group were treated with peanut oil instead of EB or flutamide. After the treatment, experimental animals were placed back to their mother for nursery.

2.. Isolation of tissue and extraction of total RNA from the tissue
-------------------------------------------------------------------

Each experimental group was consisted of 6 animals and thus 30 male rats in total were used for the present study. When the animal was reached at 4 months of age, the euthanasia was carried out in CO~2~ chamber. The male reproductive tract was extracted and placed in cold PBS. Under the dissecting microscope, the epididymis was separated from the rest of male reproductive tract and further divided into different epididymal segments. The caudal epididymis was rinsed in fresh cold PBS and quickly frozen in liquid nitrogen. The tissue was stored in --80°C until used for total RNA extraction.

To isolate total RNA from the caudal epididymis, the tissue was first homogenized in total RNA extraction solution (iNtRON Biotech, Sungnam, Korea). Isopropanol was included into the homogenized solution to precipitate total RNA, and a pellet of total RNA was collected by an ultracentrifugation at 4°C for 30 min. The pellet was rinsed in 70% EtOH once, air-dried, and dissolved in DEPC-treated RNasefree dH~2~O. Total amount and purity and quality of total RNA extracted were determined by NanoDrop Lite spectrophotometer (Thermo Scientific, Wilmington, DE, USA) and agarose gel electrophoresis, respectively. Total RNAs were stored in --80°C until used as templates for cDNA synthesis.

3.. Preparation of cDNA and performance of quantitative real-time PCR
---------------------------------------------------------------------

Construction of cDNA was carried out with 1 mg of total RNA and oligo-dT primer in ImProm-II^TM^ reverse transcription system (Promega, Madision, WI, USA). Then, reverse transcription reactions were performed in a sequence of 25°C for 5 min, 42°C for 90 min, and 70°C for 15 min. For each experimental group, cDNAs were independently generated from total RNAs isolated from four animals. The cDNAs were directly used for quantitative real-time PCR. Table [1](#T1){ref-type="table"} provides information of oligonucleotide primers utilized for real-time PCR analysis.

###### Oligonucleotide primers utilized for real-time PCR analysis

  Gene (GenBank ID)   Primer sequence (5' → 3')         Tm (°C)   PCR product size (bps)
  ------------------- --------------------------------- --------- ------------------------
  *Cx*26              \(F\) TCCTCTTCATCTTCCGCATC        55        233
  (NM_001004099)      \(R\) CCGTTTCTTTTCGTGTCTCC                  
                                                                  
  *Cx*30.3            \(F\) CCCAATGTCTGCTATGACGA        57        243
  (NM_053984)         \(R\) CACAGCAGCCTTGAAGATGA                  
                                                                  
  *Cx*31              \(F\) TTGAGCGGTGTGAACCAGTA        57        193
  (NM_019240)         \(R\) TGTTGGAGATGGGGAAGAAG                  
                                                                  
  *Cx*31.1            \(F\) CATCGTCTGCATCCTGCTTA        55        165
  (NM_019241)         \(R\) ATGAGGTCGCTTGAGAGGAA                  
                                                                  
  *Cx*32              \(F\) AGAATCATGGTGCTGGTGGT        57        235
  (NM_017251)         \(R\) CCTCAAGCCGTAGCATTTTC                  
                                                                  
  *Cx*37              \(F\) AGTGTCTGTACCTTGGATGCC       51        223
  (NM_021654)         \(R\) CAGCACACTTAGCCAAGAGC                  
                                                                  
  *Cx*40              \(F\) ATACCATTCAGCCTGGTTGC        57        189
  (NM_019280)         \(R\) CGGCCTCTTTAGCTTTCTCA                  
                                                                  
  *Cx*43              \(F\) AGCAAGCTAGCGAGCAAAAC        55        151
  (NM_012567)         \(R\) GAGTTCATGTCCAGCAGCAA                  
                                                                  
  *Cx*45              \(F\) GATCATCCTGGTTGCTACTC        51        173
  (NM_001085381)      \(R\) GATCCTCTTCATGGTCCTCT                  
                                                                  
  *Ppia*              \(F\) GGCAAATGCTGGACCAAACAC       59        196
  (NM_07101.1)        \(R\) TTAGAGTTGTCCACAGTCGGAGATG             

*Cx* : connexin; *Ppia* : peptidylprolyl isomerase A (cyclophilin A).

A reaction cocktail for real-time PCR was prepared with 1 mL of cDNA, 10 pmol of primer set, 10 mL of PCR master mixture (Finnzymes, Espoo, Finland), and dH~2~O to make a final volume of 20 mL. A pre-denaturation of the reaction mixture was carried out at 95°C for 30 sec, followed by 35 to 40 cycles of denaturation at 95°C for 30 sec, annealing at T~m~ for 30 sec, and extension at 72°C for 30 sec. At the end of each PCR, an additional extension step at 72°C for 10 min was included. Cyclophilin A (*Ppia*), the housekeeping gene, was amplified as a PCR internal control. The size of PCR products were evaluated with fractionation in 1.2% agarose gel electrophoresis.

4.. Statistical analysis and data presentation
----------------------------------------------

At least three repeats of PCR per cDNA were performed to obtain a mean and a standard error of an experimental group. Data are presented in the relative expressional ratio between *Ppia* and target *Cx* isoform. The statistical significance of the difference in mean values among experimental groups of EB or flutamide treatment was assessed by oneway ANOVA, followed by Duncan's test. The existence of statistical significance between control and experimental group was considered if *P* value was \< 0.05.

RESULTS
=======

1.. Expression of *C*x26 and *C*x30.3 genes in the caudal epididymis of adult rat administrated with estradiol benzoate or flutamide at 7 days of postnatal age
---------------------------------------------------------------------------------------------------------------------------------------------------------------

Neither EB nor flutamide treatment at 7 days of age didn't result in significant change of *Cx*26 expression in the caudal epididymis of adult rat (Fig. [1A](#F1){ref-type="fig"}). However, the treatment with a low-dose EB caused a significant decrease of *Cx*30.3 expression, while there was no statistical expressional change of *Cx*30.3 gene by a high-dose EB treatment (Fig. [1B](#F1){ref-type="fig"}). The treatment of a high-dose flutamide at 7 days of age led to a significant increase of *Cx*30.3 expression, even though no significant change of *Cx*30.3 expression was detected by a low-dose flutamide (Fig. [1B](#F1){ref-type="fig"}).

![Expression of *Cx*26 and *Cx*30.3 in the caudal epididymis of adult rat treated with EB or flutamide at 7 days of postnatal age.\
Animals were treated with either a low-dose (EB L, 0.015 μg/kg BW) or a high-dose (EB H, 1.5 μg/kg BW) EB or a lowdose (Flu L, 500 μg/kg BW) or a high-dose (Flu H, 50 mg/kg BW) flutamide. Different letters indicate statistical differences among experiment groups on transcript levels of *Cx*26 (A) or *Cx*30.3 (B) at *p*\< 0.05 level.](DR-20-237-g001){#F1}

2.. Expression of *Cx*31 and *Cx*31.1 genes in the caudal epididymis of adult rat administrated with estradiol benzoate or flutamide at 7 days of postnatal age
---------------------------------------------------------------------------------------------------------------------------------------------------------------

Expression of *Cx*31 in the caudal epididymis of adult rat was not changed by a low-dose EB treatment at 7 days of age, but a tremendous increase of *Cx*31 expression was found in the high-dose EB treated group (Fig. [2A](#F2){ref-type="fig"}). Treatments of both doses of flutamide resulted in significant increases of *Cx*31 expression, and an increase of *Cx*31 expression by a high-dose flutamide treatment was significantly higher than that by a low-dose flutamide treatment (Fig. [2A](#F2){ref-type="fig"}).

![Expression of *Cx*31 and *Cx*31.1 in the caudal epididymis of adult rat treated with EB or flutamide at 7 days of postnatal age.\
Animals were treated with either a low-dose (EB L, 0.015 μg/kg BW) or a high-dose (EB H, 1.5 μg/kg BW) EB or a lowdose (Flu L, 500 μg/kg BW) or a high-dose (Flu H, 50 mg/kg BW) flutamide. Different letters indicate statistical differences among experiment groups on transcript levels of *Cx*31 (A) or *Cx*31.1 (B) at *p*\< 0.05 level.](DR-20-237-g002){#F2}

The treatment of a low-dose EB caused a significant decrease of *Cx*31.1 expression in the adult caudal epididymis, but a significant expressional increase of *Cx*31.1 gene was observed with the treatment of a high-dose EB (Fig. [2B](#F2){ref-type="fig"}). Treatments of both flutamide doses resulted in significant increases of *Cx*31.1 expression, even though there was no difference on the degree of increment of *Cx*31.1 expression (Fig. [2B](#F2){ref-type="fig"}).

3.. Expression of *Cx*32 and *Cx*37 genes in caudal epididymis of adult rat administrated with estradiol benzoate or flutamide at 7 days of postnatal age
---------------------------------------------------------------------------------------------------------------------------------------------------------

Fig. [3A](#F3){ref-type="fig"} shows the expressional change of *Cx*32 gene in the adult caudal epididymis exposed to EB or flutamide at 7 days of postnatal age. Both EB and flutamide treatments resulted in significant increases of *Cx*32 gene expression, compared with that of control (Fig. [3A](#F3){ref-type="fig"}). Treatments with different doses of EB or flutamide didn't cause significant expressional changes of *Cx*32 gene (Fig. [3A](#F3){ref-type="fig"}).

![Expression of *Cx*32 and *Cx*37 in the caudal epididymis of adult rat treated with EB or flutamide at 7 days of postnatal age.\
Animals were treated with either a low-dose (EB L, 0.015 μg/kg BW) or a high-dose (EB H, 1.5 μg/kg BW) EB or a lowdose (Flu L, 500 μg/kg BW) or a high-dose (Flu H, 50 mg/kg BW) flutamide. Different letters indicate statistical differences among experiment groups on transcript levels of *Cx*32 (A) or *Cx*37 (B) at *p*\< 0.05 level.](DR-20-237-g003){#F3}

Expression of *Cx*37 was significantly decreased by EB treatment (Fig. [3B](#F3){ref-type="fig"}). Reduction of *Cx*37 gene expression was more significant with a low-dose EB treatment than that with a high-dose EB treatment (Fig. [3B](#F3){ref-type="fig"}). The treatment of a low-dose flutamide also induced a significant decrease of *Cx*37 gene expression, but expression of *Cx*37 gene was significantly increased by a high-dose flutamide (Fig. [3B](#F3){ref-type="fig"}).

4.. Expression of *Cx*40, *Cx*43, and *Cx*45 genes in caudal epididymis of adult rat administrated with estradiol benzoate or flutamide at 7 days of postnatal age
------------------------------------------------------------------------------------------------------------------------------------------------------------------

The treatment of a low-dose EB didn't influence on expression of *Cx*40 in the caudal epididymis, while a significant increase of *Cx*40 transcript level was detected with the treatment of a high-dose EB (Fig. [4A](#F4){ref-type="fig"}). Neither a low-dose nor a high-dose flutamide affected expression of *Cx*40 gene (Fig. [4A](#F4){ref-type="fig"}).

![Expression of *Cx*40, *Cx*43, and *Cx*45 in the caudal epididymis of adult rat treated with EB or flutamide at 7 days of postnatal age.\
Animals were treated with either a low-dose (EB L, 0.015 μg/kg BW) or a high-dose (EB H, 1.5 μg/kg BW) EB or a lowdose (Flu L, 500 μg/kg BW) or a high-dose (Flu H, 50 mg/kg BW) flutamide. Different letters indicate statistical differences among experiment groups on transcript levels of *Cx*40 (A), *Cx*43 (B), and *Cx*45 (C) at *p*\<0.05 level.](DR-20-237-g004){#F4}

Expression of *Cx*43 gene was not changed by a lowdose EB treatment, but a significant increase of *Cx*43 expression was observed with the treatment of a high-dose EB (Fig. [4B](#F4){ref-type="fig"}). Both treatments of flutamide at different doses resulted in significant increases of *Cx*43 expression, even though administration of a high-dose flutamide led to a significant increase of *Cx*43 expression than that of a low-dose flutamide (Fig. [4B](#F4){ref-type="fig"}).

There was no change of *Cx*45 gene expression by a high-dose EB treatment, even though a low-dose EB resulted in a significant decrease of *Cx*45 expression (Fig. [4C](#F4){ref-type="fig"}). No significant change of *Cx*45 expression was also detected in a low-dose flutamide-treated group (Fig. [4C](#F4){ref-type="fig"}). The treatment of a high-dose flutamide caused a significant increase of *Cx*45 expression in the adult caudal epididymis (Fig. [4C](#F4){ref-type="fig"}).

DISCUSSION
==========

Disruption of normal gene expression in the adult epididymis is frequently found with exposure to exogenous compounds during the early postnatal period. Our previous researches have demonstrated aberrant expression of *Cx* isoforms in the initial segment and corpus epididymis of adult rat treated with EB or flutamide at 7 days of postnatal age. Data from the present study also clearly shows that exposure to steroidal and/or antisteroidal material at the early postnatal development age influences on the expression of some *Cx* isoforms in the caudal epididymis of adult rat.

The exogenous treatment of EB or flutamide in neonatal rat at 7 days of postnatal age results in different expressional patterns of *Cx* isoforms within the corpus and caudal epididymis. For example, in the corpus epididymis, gene expression of *Cx*26 was significantly decreased by a highdose (1.5 mg/kg BW) EB and a low-dose (500 mg/kg BW) and a high-dose (50 mg/kg BW) flutamide treatment ([@R9]), while there was no significant change on *Cx*26 in the caudal epididymis. These findings suggest that expression of *Cx*26 gene could be regulated by estrogenic and/or androgenic materials in segment-specific manner within the epididymis. Indeed, expression of forkhead box A2 (*Faxa2*), which is one of androgen receptor coregulatory and involves in suppression of activation of lipocalin 5 by androgen, is higher in the corpus and caudal epididymis than the caput epididymis ([@R20]). Moreover, differential expression of various miRNAs among the epididymal segments has been extensively examined by other researches ([@R1]; [@R12]). Taken together, different expressional patterns of *Cx*26 gene at different epididymal regions by treatment of same exogenous materials would be reasonable to be considered. Moreover, it is speculated that expression of *Cx*26 in the corpus epididymis would not be under regulation of estrogenic and/or androgenic action. Detailed examination on expressional regulation of *Cx*26 gene in the epididymis is clearly suggested for future researches.

It is noteworthy that expression of *Cx*30.3, *Cx*31.1, *Cx*37, and *Cx*45 genes by the treatment of a low-dose (0.015 mg/kg BW) EB at 7 days of postnatal age is significantly decreased in the caudal epididymis, but either no change or significantly increased in the corpus epididymis of adult rat ([@R9]). In addition, expression of *Cx*32 gene is induced by the same treatment in both caudal and corpus epididymis ([@R9]). Moreover, the treatment of a low-dose EB at 7 days of postnatal age doesn't influence on expression of *Cx*26, *Cx*31, *Cx*40, and *Cx*43 gene in bother caudal and corpus epididymis ([@R9]). Such ununiformed outcomes on expressional patterns of *Cx* isoforms obtained from the corpus and caudal epididymis by the treatment of a low-dose EB could not be simply explainable at this point. Differential amounts of androgen and estrogen receptors along the epididymal duct are detected in the rodent ([@R21]). Thus, it is speculated that the existence of androgen receptor and/or estrogen receptor at different amount within two epididymal regions could contribute to differential expression of *Cx* isoforms in these epididymal segments. Also, differential expression of specific transcription factors and/or coregulators between the corpus and caudal epididymis ([@R1]; [@R12]) could lead into segmental-specific expression of *Cx* isoforms in the epididymis.

Comparison of data extracted from the corpus and caudal epididymis by a high-dose of EB and a low-dose and a high-dose of flutamide provides quite interesting findings. In the most of cases, these treatments at 7 days of postnatal age result in significant decreases of gene expression of *Cx* isoforms in the adult corpus epididymis ([@R9]), but the opposite results are acquired with the adult caudal epididymis treated with same materials. The exceptions are *Cx*26, *Cx*30.3, and *Cx*45 in a high-dose EB treatment, *Cx*26, *Cx*30.3, *Cx*40, and *Cx*45 in a low-dose flutamide treatment, and *Cx*26, *Cx*37, *Cx*40, and *Cx*43 ([@R9]). [@R11] have demonstrated that the administration of flutamide in prenatal boar results in morphological and functional abnormalities in the epididymis of adult boar. Especially, this research shows expressional change of *Cx*43 in the caudal epididymis, but not in the corpus epididymis ([@R11]). As seen in our previous ([@R7] & [@R9]) and present researches, *Cx*43 is the most predominant form of *Cx* isoforms in the epididymis. Thus, it is important to notice the opposite effects of high-dose EB and low-dose flutamide treatments on expression of *Cx*43 in the corpus and caudal epididymis. At this point, it is not possible to provide a clear description to explain such segmental differential expression of *Cx*43 gene at the epididymis. The existence of different concentration of androgen and/or estrogen receptor along the epididymal duct could influence on differential expression of *Cx*43 gene among different epididymal segments. Detailed molecular biological examination should be conducted to resolve a complex of transcriptional regulation of *Cx* isoforms in the epididymis.

In conclusion, the present study, in addition with previous findings in the corpus epididymis ([@R9]), provides an information which exposure to exogenous estrogenic and/ or antiandrogenic compound during the early postnatal period would deliver aberrant expression of *Cx* isoforms in the corpus and caudal epididymis. Therefore, it is supposed that such abnormal expression of *Cx* isoforms induced by endocrine-disrupting compounds during the neonatal development could eventually lead into functional defect of the epididymis.
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